The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 02, 2017
Filed:
Jul. 05, 2013
Applicant:
Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, Karnataka, IN;
Inventors:
Jayanta Haldar, Bangalore, IN;
Divakara Siva Sathyanarayana Murthy Uppu, Bangalore, IN;
Padma Akkapeddi, Bangalore, IN;
Goutham Belagula Manjunath, Bangalore, IN;
Assignee:
JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH, Bangalore, IN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C08F 220/52 (2006.01); A61K 31/787 (2006.01); C08F 210/10 (2006.01); A61K 9/14 (2006.01); C08F 222/40 (2006.01); C09D 123/22 (2006.01); C09D 135/00 (2006.01); C08L 23/22 (2006.01); C08L 35/00 (2006.01); A61L 27/54 (2006.01); A61L 29/16 (2006.01); A61L 31/16 (2006.01); C08F 8/02 (2006.01); C08F 8/12 (2006.01); C08F 8/30 (2006.01); C08F 8/32 (2006.01); C08F 8/44 (2006.01); C08F 8/48 (2006.01); B82Y 40/00 (2011.01);
U.S. Cl.
CPC ...
A61K 31/787 (2013.01); A61K 9/14 (2013.01); A61L 27/54 (2013.01); A61L 29/16 (2013.01); A61L 31/16 (2013.01); C08F 8/02 (2013.01); C08F 8/12 (2013.01); C08F 8/30 (2013.01); C08F 8/32 (2013.01); C08F 8/44 (2013.01); C08F 8/48 (2013.01); C08F 210/10 (2013.01); C08F 220/52 (2013.01); C08F 222/40 (2013.01); C08L 23/22 (2013.01); C08L 35/00 (2013.01); C09D 123/22 (2013.01); C09D 135/00 (2013.01); A61L 2300/404 (2013.01); A61L 2300/624 (2013.01); A61L 2400/12 (2013.01); B82Y 40/00 (2013.01); C08F 2800/10 (2013.01);
Abstract
The present disclosure relates to the development of antibacterial compounds and their nanoparticle compositions. Methods of making the compounds and their nanoparticle compositions, their use as medicament for the treatment of bacterial infection and also for suppressing potentially harmful inflammation are disclosed.